Lung Cancer Screening

Med Clin North Am. 2017 Jul;101(4):769-785. doi: 10.1016/j.mcna.2017.03.008.

Abstract

Lung cancer is the leading cause of cancer death in the United States. More than 80% of these deaths are attributed to tobacco use, and primary prevention can effectively reduce the cancer burden. The National Lung Screening Trial showed that low-dose computed tomography (LDCT) screening could reduce lung cancer mortality in high-risk patients by 20% compared with chest radiography. The US Preventive Services Task Force recommends annual LDCT screening for persons aged 55 to 80 years with a 30-pack-year smoking history, either currently smoking or having quit within 15 years.

Keywords: Decision making; Early detection of cancer; Lung neoplasms; Practice guidelines; Tobacco use; Tomography, X-ray computed.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Centers for Medicare and Medicaid Services, U.S.
  • Early Detection of Cancer / methods*
  • Humans
  • Lung / diagnostic imaging
  • Lung Neoplasms / chemically induced*
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / diagnostic imaging
  • Patient Participation
  • Practice Guidelines as Topic
  • Racial Groups
  • Radiography, Thoracic
  • Sensitivity and Specificity
  • Sex Factors
  • Smoking / adverse effects*
  • Smoking Cessation
  • Tomography, X-Ray Computed
  • United States / epidemiology